StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by AngelMan92on Jul 11, 2020 3:02pm

102 Views

Post# 31255868

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:UdoTest ...

Unless of course, this is bs. Either way, that makes the other email equally as possibly fake. We'll see when the numbers are shown, I guess :/

AngelMan92 wrote:
frewil11 wrote: Reply from Rebecca Yes our supply chain is set up to meet our stated testing capacity and to be able to maintain it as well.

Rebecca

Rebecca Greco
Investor Relations

And it's not saying anything that's not public knowledge, we heard this from when they said their capacity was 1000 per day.